TrialThe American journal of surgical pathology2020

Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer: Prospective Validation in a Randomized Controlled Study (SACURA Trial).

Hideki Ueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.